| Product Code: ETC335549 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for Oestrogens and Progestogens, which are hormonal compounds, in the Philippines has experienced a CAGR of 2.9%.
The Philippines oestrogens and progestogens market is driven by various factors related to women`s health and hormonal treatments. The increasing awareness about hormone replacement therapies (HRT) for menopausal symptoms and related health conditions has contributed to market growth. These hormones are also used in contraception and fertility treatments, which further propels their demand. The pharmaceutical industry`s advancements in drug formulations and delivery systems have expanded the applications of oestrogens and progestogens, driving market innovation. However, concerns about potential side effects and health risks associated with hormone therapies could impact the market`s growth trajectory.
In the Philippines Oestrogens And Progestogens Market, concerns about hormonal therapies` long-term effects could impact market growth. Addressing these concerns through rigorous research and transparent communication is a significant challenge.
The COVID-19 pandemic has moderately impacted the Philippines oestrogens and progestogens market. The pharmaceutical sector, which utilizes these hormones in medications, has continued to operate during the pandemic. However, disruptions in the supply chain and manufacturing processes may have led to minor delays in production and distribution.
Key Players of the Market include United Laboratories Inc., Bayer Philippines Inc., Pfizer Philippines Inc., Wyeth Philippines Inc., GSK Philippines Inc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Oestrogens And Progestogens Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Oestrogens And Progestogens Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Oestrogens And Progestogens Market - Industry Life Cycle |
3.4 Philippines Oestrogens And Progestogens Market - Porter's Five Forces |
3.5 Philippines Oestrogens And Progestogens Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Oestrogens And Progestogens Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Oestrogens And Progestogens Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about women's health and hormonal imbalances |
4.2.2 Growing prevalence of hormonal disorders and related conditions |
4.2.3 Rising healthcare expenditure and improved access to healthcare services |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and marketing |
4.3.2 High competition from generic drug manufacturers |
4.3.3 Concerns regarding potential side effects and long-term health risks associated with hormone therapy |
5 Philippines Oestrogens And Progestogens Market Trends |
6 Philippines Oestrogens And Progestogens Market, By Types |
6.1 Philippines Oestrogens And Progestogens Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Oestrogens And Progestogens Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Philippines Oestrogens And Progestogens Market Revenues & Volume, By Aglepristone, 2021-2031F |
6.1.4 Philippines Oestrogens And Progestogens Market Revenues & Volume, By Mifepristone, 2021-2031F |
6.1.5 Philippines Oestrogens And Progestogens Market Revenues & Volume, By Asoprisnil, 2021-2031F |
6.1.6 Philippines Oestrogens And Progestogens Market Revenues & Volume, By Telapristone, 2021-2031F |
6.1.7 Philippines Oestrogens And Progestogens Market Revenues & Volume, By Ulipristal Acetate, 2021-2031F |
6.2 Philippines Oestrogens And Progestogens Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Oestrogens And Progestogens Market Revenues & Volume, By Pharmacy, 2021-2031F |
6.2.3 Philippines Oestrogens And Progestogens Market Revenues & Volume, By Hospital, 2021-2031F |
6.2.4 Philippines Oestrogens And Progestogens Market Revenues & Volume, By Department Of Endocrinology, 2021-2031F |
7 Philippines Oestrogens And Progestogens Market Import-Export Trade Statistics |
7.1 Philippines Oestrogens And Progestogens Market Export to Major Countries |
7.2 Philippines Oestrogens And Progestogens Market Imports from Major Countries |
8 Philippines Oestrogens And Progestogens Market Key Performance Indicators |
8.1 Number of prescriptions for oestrogens and progestogens |
8.2 Patient adherence rate to prescribed hormone therapy |
8.3 Number of healthcare providers offering hormone replacement therapy |
8.4 Percentage of women undergoing hormone replacement therapy as part of menopausal management |
8.5 Rate of new product developments or innovations in the oestrogens and progestogens market |
9 Philippines Oestrogens And Progestogens Market - Opportunity Assessment |
9.1 Philippines Oestrogens And Progestogens Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Oestrogens And Progestogens Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Oestrogens And Progestogens Market - Competitive Landscape |
10.1 Philippines Oestrogens And Progestogens Market Revenue Share, By Companies, 2024 |
10.2 Philippines Oestrogens And Progestogens Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here